IP3 production in A10 cells, an established aortic smooth muscle cultured cell line: Effects of agonist administration procedure and culture conditions

General Pharmacology

Volumn 32, Issue 1, 1999, Pages 115-121

  Ishibashi, Takaharu ^a   Yoshida, Yutaka ^a   Imai, Shoichi ^a   Nishio, Matomo ^b  

^a NIIGATA UNIVERSITY   (Japan)

^b KANAZAWA MEDICAL UNIVERSITY   (Japan)

Author keywords

Aortic vascular smooth muscle cells (A10); Cyclic GMP dependent protein kinase; Inositol trisphosphate (IP3); Low serum culture; Vasopressin

Indexed keywords

CYCLIC GMP DEPENDENT PROTEIN KINASE; INOSITOL TRISPHOSPHATE; VASOPRESSIN; CALCIUM; CYCLIC GMP; INOSITOL 1,4,5 TRISPHOSPHATE; VASOPRESSIN DERIVATIVE;

ANIMAL CELL; AORTA MEDIA; ARTICLE; CARBOHYDRATE METABOLISM; CONTROLLED STUDY; CULTURE MEDIUM; EMBRYO; MUSCLE FIBER CULTURE; NONHUMAN; PRIORITY JOURNAL; RAT; SERUM; ANIMAL; AORTA; BIOSYNTHESIS; CELL LINE; METABOLISM; PHYSIOLOGY; VASCULAR SMOOTH MUSCLE;

ANIMALS; AORTA; CALCIUM; CELL LINE; CULTURE MEDIA; CYCLIC GMP; INOSITOL 1,4,5-TRISPHOSPHATE; MUSCLE, SMOOTH, VASCULAR; RATS; VASOPRESSINS;

EID: 0032589815     PISSN: 03063623     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-3623(98)00103-7     Document Type: Article

References (25)

1. Cornwell T.L., Soff G.A., Traynor A.E., Lincoln T.M. Regulation of the expression of cyclic GMP-dependent protein kinase by cell density in vascular smooth muscle cells. J. Vasc. Res. 31:1994;330-337.
2. Downes C.P., Michell R.H. The polyphosphoinositide phosphodiesterases of erythrocyte membranes. Biochem. J. 194:1981;129-136.
3. Hirata M., Kohse K.P., Chang C.-H., Ikebe T., Murad F. Mechanism of cyclic GMP inhibition of inositol phosphate formation in rat aorta segments and cultured bovine aortic smooth muscle cells. J. Biol. Chem. 265:1990;1268-1273.
4. 3) production in a cultured aortic smooth muscle cell line. Jpn. J. Pharmac. 73(Suppl. I):1997;198P.
5. Kimes B.W., Brandt B.L. Characterization of two putative smooth muscle cell lines from rat thoracic aorta. Exp. Cell Res. 98:1976;349-366.
6. 1D-adrenoceptor antagonist, isolated from Fissistigma glaucescens. Br. J. Pharmac. 112:1994;1174-1180.
7. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (Lond.). 227:1970;680-685.
8. Lum Min S.A., Tabrizchi R. Effects of 8-bromoguanosine 3′:5′-cyclic monophosphate on phenylephrine-induced phosphatidylinositol hydrolysis and contraction in rat caudal artery. Br. J. Pharmac. 116:1995;1697-1703.
9. Nambi P., Whitman M., Gessner G., Aiyar N., Crooke S.T. Vasopressin-mediated inhibition of atrial natriuretic factor-stimulated cGMP accumulation in an established smooth muscle cell line. Proc. Natl. Acad. Sci. USA. 83:1986;8492-8495.
10. Neuser D., Bellemann P. Receptor binding, cGMP stimulation and receptor desensitization by atrial natriuretic peptides in cultured A10 vascular smooth muscle cells. FEBS Lett. 209:1986;347-351.
11. 2+ responses in rat A10 vascular smooth muscle cells. Circ. Res. 74:1994;173-181.
12. 3H]-phosphatidylbutanol accumulation in A10 vascular smooth muscle cell. Br. J. Pharmac. 107:1992;109-115.
13. Rapoport R.M. Cyclic guanosine monophosphate inhibition of contraction may be mediated through inhibition of phosphatidylinositol hydrolysis in rat aorta. Circ. Res. 58:1984;407-410.
14. Rosati C., Cavalier S., Braquet P., Berthet P., Tarrade T., Ruchoux M.-M., Garay R. A mechanical stress increases sodium ion content in vascular smooth muscle cells through a calcium-dependent pathway. Prevention by cicletanine via a cyclo-oxygenase product J. Hypertens. 7(Suppl. 6):1989;S322-S323.
15. Rosati C., Garay R. Flow-dependent stimulation of sodium and cholesterol uptake and cell growth. J. Hypertens. 9:1991;1029-1033.
16. Saward L., Zahradka P. The angiotensin Type 2 receptor mediates RNA synthesis in A10 vascular smooth muscle cells. J. Mol. Cell. Cardiol. 28:1996;499-506.
17. Takai Y., Kikkawa U., Kaibuchi K., Nishizuka Y. Membrane phospholipid metabolism and signal transduction for protein phosphorylation. Adv. Cyclic Nucleotide Prot. Phosphorylation Res. 18:1984;119-158.
18. Webb M.L., Dickinson K.E.J., Delaney C.L., Lie E.C.-K., Seafino R., Cohen R.B., Monshizadegan H., Moreland S. The endothelin receptor antagonist, BQ-123, inhibits angiotensin II-induced contractions in rabbit aorta. Biochem. Biophys. Res. Commun. 185:1992;887-892.
19. Wilkers L.C., Boarder M.R. Characterization of the endothelin binding site on bovine adrenomedullary chromaffin cells. Comparison with vascular smooth muscle cells. Evidence for receptor heterogeneity J. Pharmac. Exp. Ther. 256:1991;628-633.
20. Xuan Y.-T., Glass P.S.A. Propofol regulation of calcium entry pathways in cultured A10 and aortic smooth muscle cells. Br. J. Pharmac. 117:1996;5-12.
21. Xuan Y.-T., Su Y.-F., Chang K.-J., Watkins W.D. A pertussis/cholera toxin sensitive G-protein may mediate vasopressin-induced inositol phosphate formation in smooth muscle cell. Biochem. Biophys. Res. Commun. 146:1987;898-906.
22. Xuan Y.-T., Watkins W.D., Whorton A.R. Regulation of endothelin-mediated calcium mobilization in vascular smooth muscle cells by isoproterenol. Am. J. Physiol. 260:1991;C492-C502.
23. 2+ mobilization in smooth muscle cell. Biochem. Biophys. Res. Commun. 160:1989;758-764.
24. 2+ pump ATPase of vascular smooth muscle via phosphorylation of a 240-kDa protein. J. Biol. Chem. 266:1991;19819-19825.
25. Yu S.M., Cheng Z.J., Guh J.H., Lee F.Y., Kuo S.C. Mechanism of anti-proliferation caused by YC-1, an indazole derivative, in cultured rat A10 vascular smooth-muscle cells. Biochem. J. 306:1995;787-792.